Zuliani G

References (15)

Title : Acetyl-cholinesterase-inhibitors reconsidered. A narrative review of post-marketing studies on Alzheimer's disease - Zuliani_2024_Aging.Clin.Exp.Res_36_23
Author(s) : Zuliani G , Zuin M , Romagnoli T , Polastri M , Cervellati C , Brombo G
Ref : Aging Clin Exp Res , 36 :23 , 2024
Abstract :
PubMedSearch : Zuliani_2024_Aging.Clin.Exp.Res_36_23
PubMedID: 38321321

Title : Serum Beta-Secretase 1 Activity Is a Potential Marker for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Dementia: A Pilot Study - Saraceno_2024_Int.J.Mol.Sci_25_
Author(s) : Saraceno C , Cervellati C , Trentini A , Crescenti D , Longobardi A , Geviti A , Bonfiglio NS , Bellini S , Nicsanu R , Fostinelli S , Mola G , Riccetti R , Moretti DV , Zanetti O , Binetti G , Zuliani G , Ghidoni R
Ref : Int J Mol Sci , 25 : , 2024
Abstract :
PubMedSearch : Saraceno_2024_Int.J.Mol.Sci_25_
PubMedID: 39125924

Title : High plasma homocysteine levels predict the progression from mild cognitive impairment to dementia - Zuliani_2024_Neurochem.Int_177_105763
Author(s) : Zuliani G , Brombo G , Polastri M , Romagnoli T , Mola G , Riccetti R , Seripa D , Trentini A , Cervellati C
Ref : Neurochem Int , 177 :105763 , 2024
Abstract :
PubMedSearch : Zuliani_2024_Neurochem.Int_177_105763
PubMedID: 38723899

Title : Paraoxonase 1 activity in patients with Alzheimer disease: Systematic review and meta-analysis - Zuin_2023_Chem.Biol.Interact_14ChEPon_382_110601
Author(s) : Zuin M , Rosta V , Trentini A , Bosi C , Zuliani G , Cervellati C
Ref : Chemico-Biological Interactions , 382 :110601 , 2023
Abstract :
PubMedSearch : Zuin_2023_Chem.Biol.Interact_14ChEPon_382_110601
PubMedID: 37330180

Title : Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis - Zuin_2022_Dis.Markers_2022_4264314
Author(s) : Zuin M , Trentini A , Marsillach J , D'Amuri A , Bosi C , Roncon L , Passaro A , Zuliani G , Mackness M , Cervellati C
Ref : Dis Markers , 2022 :4264314 , 2022
Abstract :
PubMedSearch : Zuin_2022_Dis.Markers_2022_4264314
PubMedID: 35308142

Title : Acetyl-cholinesterase-inhibitors slow cognitive decline and decrease overall mortality in older patients with dementia - Zuin_2022_Sci.Rep_12_12214
Author(s) : Zuin M , Cherubini A , Volpato S , Ferrucci L , Zuliani G
Ref : Sci Rep , 12 :12214 , 2022
Abstract :
PubMedSearch : Zuin_2022_Sci.Rep_12_12214
PubMedID: 35842477

Title : HDL Proteome and Alzheimer's Disease: Evidence of a Link - Marsillach_2020_Antioxidants.(Basel)_9_
Author(s) : Marsillach J , Adorni MP , Zimetti F , Papotti B , Zuliani G , Cervellati C
Ref : Antioxidants (Basel) , 9 : , 2020
Abstract :
PubMedSearch : Marsillach_2020_Antioxidants.(Basel)_9_
PubMedID: 33287338

Title : Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer's Disease and Vascular Dementia - Romani_2020_Antioxidants.(Basel)_9_
Author(s) : Romani A , Trentini A , Flier WMV , Bellini T , Zuliani G , Cervellati C , Teunissen CE
Ref : Antioxidants (Basel) , 9 : , 2020
Abstract :
PubMedSearch : Romani_2020_Antioxidants.(Basel)_9_
PubMedID: 32466344

Title : Sex Difference Impacts on the Relationship between Paraoxonase-1 (PON1) and Type 2 Diabetes - Rosta_2020_Antioxidants.(Basel)_9_
Author(s) : Rosta V , Trentini A , Passaro A , Zuliani G , Sanz JM , Bosi C , Bonaccorsi G , Bellini T , Cervellati C
Ref : Antioxidants (Basel) , 9 : , 2020
Abstract :
PubMedSearch : Rosta_2020_Antioxidants.(Basel)_9_
PubMedID: 32751395

Title : Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development - Cervellati_2019_Minerva.Med_110_238
Author(s) : Cervellati C , Valacchi G , Tisato V , Zuliani G , Marsillach J
Ref : Minerva Med , 110 :238 , 2019
Abstract :
PubMedSearch : Cervellati_2019_Minerva.Med_110_238
PubMedID: 30334443

Title : Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage - Cervellati_2019_Atherosclerosis_285_64
Author(s) : Cervellati C , Vigna GB , Trentini A , Sanz JM , Zimetti F , Dalla Nora E , Morieri ML , Zuliani G , Passaro A
Ref : Atherosclerosis , 285 :64 , 2019
Abstract :
PubMedSearch : Cervellati_2019_Atherosclerosis_285_64
PubMedID: 31029939

Title : Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases - Castellazzi_2016_Int.J.Biochem.Cell.Biol_81_356
Author(s) : Castellazzi M , Trentini A , Romani A , Valacchi G , Bellini T , Bonaccorsi G , Fainardi E , Cavicchio C , Passaro A , Zuliani G , Cervellati C
Ref : International Journal of Biochemistryistry & Cell Biology , 81 :356 , 2016
Abstract :
PubMedSearch : Castellazzi_2016_Int.J.Biochem.Cell.Biol_81_356
PubMedID: 27312742

Title : PON-1 and ferroxidase activities in older patients with mild cognitive impairment, late onset Alzheimer's disease or vascular dementia - Cervellati_2015_Clin.Chem.Lab.Med_53_1049
Author(s) : Cervellati C , Romani A , Bergamini CM , Bosi C , Sanz JM , Passaro A , Zuliani G
Ref : Clinical Chemistry & Laboratory Medicine , 53 :1049 , 2015
Abstract :
PubMedSearch : Cervellati_2015_Clin.Chem.Lab.Med_53_1049
PubMedID: 25490030

Title : Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study - Cervellati_2015_J.Neurochem_135_395
Author(s) : Cervellati C , Trentini A , Romani A , Bellini T , Bosi C , Ortolani B , Zurlo A , Passaro A , Seripa D , Zuliani G
Ref : Journal of Neurochemistry , 135 :395 , 2015
Abstract :
PubMedSearch : Cervellati_2015_J.Neurochem_135_395
PubMedID: 26178739

Title : Underrecognition and undertreatment of dementia in italian nursing homes - Cherubini_2012_J.Am.Med.Dir.Assoc_13_759 e7
Author(s) : Cherubini A , Ruggiero C , Dell'aquila G , Eusebi P , Gasperini B , Zengarini E , Cerenzia A , Zuliani G , Guaita A , Lattanzio F
Ref : J Am Med Dir Assoc , 13 :759 e7 , 2012
Abstract :
PubMedSearch : Cherubini_2012_J.Am.Med.Dir.Assoc_13_759 e7
PubMedID: 22727993